Inmune Bio, Inc (INMB) insider trading
Every open-market stock purchase and sale by Inmune Bio, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- Last insider buy: David J Moss (CFO), $52.9K, 2 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales). Last close $1.54 on Oct 22, 2026.
Recent INMB insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 15, 2026 | Ronnie Duane Clark (Director) | Bought (not open market) | — |
| Sep 15, 2026 | James Sapirstein (Director) | Bought (not open market) | — |
| Jul 2, 2026 | Scott Juda (Director) | Bought (not open market) | $20.7K |
| Jul 2, 2026 | David J Moss (CEO) | Bought (not open market) | $12.6K |
| Jul 2, 2026 | Mark William Lowdell (C-suite exec) | Bought (not open market) | $10.1K |
| Jul 2, 2026 | Scott Juda (Director) | Bought (not open market) | $1.9K |
| Jul 2, 2026 | David J Moss (CEO) | Bought (not open market) | $1.1K |
| Jul 2, 2026 | Mark William Lowdell (C-suite exec) | Bought (not open market) | $901 |
| Dec 1, 2025 | Mark William Lowdell (C-suite exec) | Bought (not open market) | — |
| Dec 1, 2025 | Timothy j Schroeder (Director) | Bought (not open market) | — |
| Dec 1, 2025 | Scott Juda (Director) | Bought (not open market) | — |
| Dec 1, 2025 | Cory Randall Ellspermann (CFO) | Bought (not open market) | — |
| Dec 1, 2025 | Marcia Allen (Director) | Bought (not open market) | — |
| Dec 1, 2025 | David J Moss (CEO) | Bought (not open market) | — |
| Dec 1, 2025 | James Kelly Ganjei (Director) | Bought (not open market) | — |
| Nov 18, 2025 | Mark William Lowdell (C-suite exec) | Sold (not open market) | $3.1M |
| Nov 18, 2025 | David J Moss (CEO) | Sold (not open market) | $3.1M |
| Nov 18, 2025 | David J Moss (CEO) | Sold (not open market) | $1.6M |
| Nov 18, 2025 | David J Moss (CEO) | Sold (not open market) | $1.5M |
| Nov 18, 2025 | David J Moss (CEO) | Sold (not open market) | $1.2M |
| Nov 18, 2025 | David J Moss (CEO) | Sold (not open market) | $1.1M |
| Nov 18, 2025 | David J Moss (CEO) | Sold (not open market) | $1.1M |
| Nov 18, 2025 | David J Moss (CEO) | Sold (not open market) | $1M |
| Nov 18, 2025 | Mark William Lowdell (C-suite exec) | Sold (not open market) | $992K |
| Nov 18, 2025 | Cory Randall Ellspermann (CFO) | Sold (not open market) | $842K |
Who's trading INMB
- James Sapirstein, Director: other filings, last Sep 15, 2026
- Ronnie Duane Clark, Director: other filings, last Sep 15, 2026
- Scott Juda, Director: other filings, last Jul 2, 2026
- Mark William Lowdell, C-suite exec: other filings, last Jul 2, 2026
- David J Moss, CEO: other filings, last Jul 2, 2026
- Marcia Allen, Director: other filings, last Dec 1, 2025
- Cory Randall Ellspermann, CFO: other filings, last Dec 1, 2025
- James Kelly Ganjei, Director: other filings, last Dec 1, 2025
- Timothy j Schroeder, Director: other filings, last Dec 1, 2025
Get free alerts when an insider at Inmune Bio, Inc files a new trade →